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Objective: to investigate the effect of clopidogrel combined with aspirin or aspirin alone on fibromyointimal hyperplasia
(FIMH) in a bypass model with native vein grafts (NVG) and biocompound grafts (BCG).
Design: twelve Beagle dogs were randomised into two equal groups. In each animal NVG and a BCG were interposed
in the common carotid arteries. Postoperatively, Group 1 received clopidogrel (200 mg/d) and aspirin (100 mg/d) and
Group 2 received aspirin (100 mg/d) alone.
Methods: the BCG was constructed by sheathing the ipsilateral jugular vein with highly flexible metal mesh tubing.
After 30 days the grafts were harvested and pressure fixed. FIMH was determined by morphometry.
Results: the average wall thickness of the BCG was significantly lower than that of the NVG in both groups (0.26
(SD)0.02 mm vs 0.47 (SD)0.15 mm, p=0.04 and 0.28 (SD)0.05 mm vs 0.70 (SD)0.29 mm, p=0.01, respectively). For
BCG treated with aspirin, the wall cross section area was lower (5.0 (SD)0.6 mm2 vs 9.1 (SD)3.3 mm2, p=0.02) and the
lumen larger (25.2 (SD)5.9 mm2 vs 9.7 (SD)3.4 mm2, p<0.01) than for the NVG. There was also a difference in the
lumen cross section area of the NVG, which was larger after combined therapy with clopidogrel and aspirin (17.9
(SD)7.8 mm2 vs 9.7 (SD)3.4 mm2, p=0.04).
Conclusions: in this dog model the sheathing of vein grafts effectively prevents FIMH following bypass surgery.
Clopidogrel is effective in NVG.
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Introduction The aims of the study were to investigate the effect
of sheathing with biocompound grafts (BCG) as com-
Grafting with autogenous vein is the established sur- pared to native vein grafts (NVG) on FIMH, and
to assess potential additional benefits of combinedgical treatment for peripheral and coronary artery
disease.1,2 However, the long-term outcome is jeop- therapy with clopidogrel and aspirin as compared to
standard therapy with aspirin alone on FIMH.ardised.
Vein graft failure is due to progressive fibro-
myointimal hyperplasia (FIMH) and atherosclerosis.3–9
Animal studies have shown that sheathing the by-
pass with a biocompound mesh tubing9–13 reduces the Materials and Methods
wall stress and is the development of FIMH.13 Platelet
inhibitors also seem to be effective14 by reducing plate- Studies were performed with Beagle dogs (n=12,
let adhesion and consequently the release of platelet weight 13–17 kg) that received humane care according
derived growth factor (PDGF). The ADP-dependent to GLP (Good Laboratory Practice) standards.
inhibitor clopidogrel has been shown to inhibit intimal Preoperatively the animals were randomly divided
proliferation in an arterial injury model in rabbits.15 into two groups for the different medical therapy
regimens (blinded randomised study). With respect to
∗ Please address all correspondence to: H. R. Zurbru¨gg, Deutsches sheathing the study open randomised. As treatmentHerzzentrum Berlin, Dept. of Cardiovascular and Thoracic Surgery,
Augustenburger Platz 1, 13353 Berlin, Germany. with aspirin is a standard therapy in vascular and
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cardiovascular surgery, the study did not envisage the
necessity of an untreated control group. Group 1 (n=
6) received clopidogrel (200 mg/d) combined with
aspirin (100 mg/d). This dose was considered as effect-
ive and enhanced by aspirin.16 Group 2 (n=6) received
monotherapy of aspirin (100 mg/d). The animals were
subjected to premedication, anaesthesia, and anti-
biotics (halothane, propofol, amoxicillin). One native
vein graft (NVG) on one side and one biocompound
graft (BCG), constructed with the ipsilateral jugular
vein sheathed with a mesh tubing, were interposed in
the CCAs. The sites were randomly selected.
Intraoperatively, the right common carotid artery
was exposed first. Then the ipsilateral jugular vein
was dissected, rinsed in iso-osmotic sodium chloride Fig. 1. Longitudinal section of the proximal anastomosis of an
interposed biocompound graft (BCG) in the carotid artery of a whitesolution, which contained heparin 2 IU/ml, and stored
Landrace pig, after 5 days. The mesh tubing (empty holes) effectivelyin the same solution at room temperature until needed. prevents the jugular vein (left) from dilatation. The graft diameter
A one centimetre segment of the artery was removed is comparable with the diameter of the CCA (right). (Verhoeff–van
Gieson stain, original magnification ×1.6.)and replaced either with a reversed segment of the
native jugular vein or with a vein segment sheathed
by the biocompound procedure. The BCG was con-
by means of an analogue camera (CF 15/4 MC, Kappastructed by sheathing intraoperatively the autologous
Messtechnik, Gleichen, F.R.G.) fitted with a macro lens,vein with a highly flexible mesh tubing, consisting of
transferred to PC memory by a frame grabber (PCsurgical stainless steel. The mesh tubing was pulled
image SC, Matrix Vision, Oppenweiler, G.R.G.) andover the entire length of the vein with the aid of an
analysed with Image Pro (IP 3.01, Media Cybernetics,applicator and then bonded with fibrin sealant to
Silver Spring, U.S.A.). Areas of the distended luminathe vein wall. The procedure has previously been
of the perfusion-fixed vessels were traced in automaticdescribed in detail.17 Both grafts were implanted with-
mode. The wall cross-sectional area was calculated byout longitudinal tension. Anastomoses were per-
subtraction of the lumen area from the area enclosedformed end-to-end with a 6-0 Prolene one-stitch suture
by the manually traced outer boundaries of the mediatechnique. The tubing prevented extensive dilatation
of the graft. The mean wall thickness was calculatedof the graft. There was only a small difference in the
according to the following formula:diameter of the BCG and the common carotid artery
after reopening of the clamps. The effect is dem-
onstrated in a longitudinal section of a BCG and CCA
WTH=
WA+LA−LA
harvested from a white Landrace pig of another study
(Fig. 1). The animals were allowed to recover and
fed a normal diet. After 4 weeks, the animals were where WTH=wall thickness, WA=wall area, and LA=
sacrificed after the i.v. administration of 10 000 IU of luminal area.
heparin. The common carotid artery was fixed by
perfusion at a continuous pressure at 100 mmHg for
10 min with buffered 3.6% formaldehyde (or 8% form-
alin). A tissue block was excised that comprised the Statistics
graft with its proximal and distal anastomoses and
the surrounding fascia and muscles. The study was designed as a prospective experimental
After further fixation by immersion in form- study randomised with respect to medical treatment
aldehyde, the muscle and soft tissues around the graft and paired with respect to the type of surgical inter-
were removed. As many as 3–4 mm segments of the vention (BCG vs NVG). As a normal distribution of
graft as possible were embedded in paraffin and after all data could be asserted by the Kolmogorov–Smirnov
removal of the steel fibres with the forceps, cut at a test, means and standard deviations were used to
nominal microtome setting of 3 m and stained with describe data and parametric analyses were used as
hematoxylin and eosin and Verhoeff-van Gieson’s appropriate test statistics. For comparing the ran-
domised groups an unpaired t-test was used. Thestain. Video images of the cross-sections were obtained
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Fig. 2. Cross section of an interposed biocompound graft (BCG) in
the common carotid artery of a beagle dog after 4 weeks. The empty
holes of the mesh tubing fibers are clearly visible. The animal was
treated with clopidogrel and aspirin. (Verhoeff–van Gieson stain,
original magnification ×1.6.)
Fig. 4. Cross section of a biocompound graft (BCG) 4 weeks after
interposition in the common carotid artery of a beagle dog and
medical treatment with aspirin only. The fibres of the BCG appear
as empty holes. Remarkable is the low degree of fibromyointimal
hyperplasia (FIMH). (Verhoeff–van Gieson stain, original mag-
nification ×20.)
Fig. 3. Corresponding cross section of an interposed native vein
graft (NVG) of Figure 2. (Verhoeff–van Gieson stain, original mag-
nification ×1.6.)
significance level was set at 5%. Adjustment for mul-
tiple comparisons was done using a modified Bon-
ferroni correction.18
Results
One NVG in the clopidogrel/aspirin group (Group 1)
Fig. 5. Corresponding native vein graft (NVG) contralateral to the
was occluded. The date of occlusion was unknown. implant of Figure 4. Fibromyointimal hyperplasia (FIMH) is marked.
(Verhoeff–van Gieson stain, original magnification ×20.)This graft was excluded from the analysis. All the
other grafts were patent 4 weeks after implantation.
As an illustration, graft cross sections of an animal FIMH, as well as medial thickening, is more marked
in the NVG than in the BCG. The higher magnificationtreated with clopidogrel and aspirin were given. The
figures show cross sections of an interposed BCG (Fig. demonstrates the low degree of FIMH in the BCG (Fig.
4) compared with the NVG (Fig. 5).2) and of the corresponding interposed NVG (Fig. 3).
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Table 1. Wall area, luminal area and wall thickness in biocompound grafts (BCG) and native vein grafts (NVG) stratified with respect
to concomitant medical treatment.
Clopidogrel/aspirin Aspirin p value (adjusted
Group 1 Group 2 p value)
Wall area (mm2) BCG 4.9 (SD)0.5 (n=6) 5.0 (SD)0.6 (n=6) 0.75 (–)
NVG 7.6 (SD)3.2 (n=5) 9.1 (SD)3.3 (n=6) 0.48 (–)
p value (adjusted p value) 0.10 (–) 0.02 (0.08)
Lumen area (mm2) BCG 28.4 (SD)7.6 (n=6) 25.2 (SD)5.9 (n=6) 0.44 (–)
NVG 17.9 (SD)7.8 (n=5) 9.7 (SD)3.4 (n=6) 0.04 (0.18)
p value (adjusted p value) 0.06 (–) Ζ0.01 (0.02)
Wall thickness (mm) BCG 0.26 (SD)0.02 (n=6) 0.28 (SD)0.05 (n=6) 0.45 (–)
NVG 0.47 (SD)0.15 (n=5) 0.70 (SD)0.29 (n=6) 0.14 (–)
p value (adjusted p value) 0.04 (0.16) 0.01 (0.04)
n=number of grafts. p values and Bonferroni adjusted p values given.
The results of morphometry are summarised in seems to be very effective in native vein grafts, whereas
Table 1. All values were normally distributed. The there seems to be only a negligible effect in the bio-
average wall thickness of the BCG was significantly compound grafts. As a consequence the t-value of the
lower than that of the NVG in both groups (0.26 influence of medical therapy on luminal area in the
(SD)0.02 mm vs 0.47 (SD)0.15 mm, p=0.04 and 0.28 NVG group was rather high and statistically significant
(SD)0.05 mm vs 0.70 (SD)0.29 mm, p=0.01, re- without post-hoc adjustments of significance levels.
spectively). For BCG treated with aspirin, the wall The use of this conservative approach to adjust for
cross section area was lower (5.0 (SD)0.6 mm2 vs 9.1 multiple comparisons may place undue importance
(SD)3.3 mm2, p=0.02) and the lumen larger (25.2 on formal hypothesis testing and has been ques-
(SD)5.9 mm2 vs 9.7 (SD)3.4 mm2, pΖ0.01) than for the tioned.22 With respect to these conservative ad-
NVG. There was also a difference in the lumen cross justments for multiple comparisons the power of the
section area of the NVG, which was larger after com- study was obviously too low to demonstrate the sig-
bined therapy with clopidogrel and aspirin (17.9 nificance of the impact of the different medical treat-
(SD)7.8 mm2 vs 9.7 (SD)3.4 mm2, p=0.04). ments. It should be noted that the presented study
provides data for estimating the necessary power for
further investigations of the impact ASS+ clopidogrel
therapy when compared with ASS alone on FIMH.Discussion
However, the improvement by combined ASS +
clopidogrel therapy when compared with ASS aloneBypass with autogenous vein remains the surgical
is a very relevant issue and is based on sound patho-treatment of choice for lower limb ischaemia but its
physiological reasoning. As the lumen, and thereforelong-term success is impaired by the development of
also the diameter, is greater in Group 1, one wouldFIMH.19,20
also expect, according to the Laplace’s Law, thickerTo date, perivenous sheathing and aspirin have been
vessel walls when compared with Group 2. But theshown to reduce FIMH in experimental models.6,9–14
contrary effect was observed. In Group 1 with theThe novel anti-platelet agent, clopidogrel, may act
combined therapy and the larger diameter, the vesselsynergistically with aspirin to reduce vascular events
wall had a tendency to be thinner when comparedand inhibit FIMH.15,16,21
with Group 2. This underlines the effectiveness of theFor these reasons, in the present study, the effect of
combined therapy.a commercially available sheathing method (bio-
Independent of pharmacological prophylaxis,compound graft17) combined with aspirin or aspirin
sheathing of the vein wall significantly reduces itsand clopidogrel on FIMH was investigated.
thickness. The highly flexible mesh tubing used forThe impact of therapy with clopidogrel and ASS vs
the BCG prevented extensive dilatation of the graft.ASS alone on FIMH was only small when compared
There was only a small difference in the diameter ofwith the effect of sheathing. It did not reach sig-
the BCG and the common carotid artery after re-nificance, if post-hoc adjustments of significance levels
opening the clamps, whereas the unsheathed NVGfor false positive errors were made. Yet wall area
dilated to a considerably larger size. Therefore, tur-measurements were consistently higher, and lumen
bulence and low shear stress were more important inarea measurements were uniformly lower in all groups
treated with ASS only. Combined medical therapy NVG when compared with BCG. They can promote
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